Free Newsletter
Investigators rejuvenate stem cells in aging study
Research at UC Berkeley is pointing the way to new therapies that can blunt or even reverse the effects of aging on muscles. In a new study led by Irina Conboy, a team of scientists determined that a molecule called TGF-beta played a key role in the deterioration of muscles. Blocking that pathway in mice reversed the physical effect in older mice. The researchers used RNAi technology to silence the molecule and then used snake venom to damage their muscles in the experiment. Older mice were able to produce new stem cells to repair the muscles, much the way that young mice were able to.
"We are one step closer to having a point of intervention where we can rejuvenate the body's own stem cells so we don't have to suffer from some of the debilitating diseases associated with aging," said the study's lead author, Morgan Carlson, a recent Ph.D. graduate of Conboy's lab.
- read the report from MIT Technology Review
Related Articles:
Resveratrol potential fires interest in longevity drugs
Anti-aging study finds enzymes protect cells
Biotechs pursue anti-aging treatments
Longevity gene may be key to living past 100
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: